| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |